Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . March 9th, 1998

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Suicide Gene Therapy - Genetically Engineered Tumor Cells Mediate Bystander Effect

Cancer Gene Therapy - Immunotoxin DNA Immunization Stimulates Strong Anti-Tumor Activity

Cancer Immunotherapy - IL-12 Immunotherapy Superior to GM-CSF or B7-1 Transfection In Vivo

Unusual Presentation - First Human Case of Mycobacterium aurum Reported

Acute Myelogenous Leukemia - International Phase III Trial in AML Initiated

Bone Marrow Cancer - Hycamtin Shows Activity in Multiple Myeloma

Cancer Risks - Flawed Radiation Data Puts Elderly and Children at Risk

Cancer Therapies - Marketing Approval Received for Taxotere in China

Cancer Therapies - FDA Accepts New Drug Application for MitoExtra

Cancer Treatments - 'Renaissance' for High Dose Radiation Treatment

Colon Cancer - Researchers Present Comparative Data on NuMA Cancer Test

Drug Development - Option Exercised To Develop Therapeutic Protein

Drug Development - Anzemet Available in the U.S. for Oncology and Surgery Patients

Education and Prevention (Prostate Cancer) - FHS Quality Initiatives Division Launches Cancer Education Program

Endometrial Cancer - Research Broadened Into Potent Antifolate Compound

Genetics - New Tumor Suppressor Gene for Breast and Lung Cancer Identified

Industry News (Joint Venture) - Collaboration to Jointly Develop And Commercialize Peripheral Neuropathy Drugs

Industry News (Patents and Technologies) - Developments for PadKit Technology Announced

Insurance - Medicare Reimburses Cancer Patients for Kytril Tablets

Melanoma - Researchers Say Genetics Plays Role in Skin Cancer

Cancer Immunotherapy - "Intratumoral Injection of Adenovirus Expressing a Fusion Protein RM4/TNF-(alpha) Induces Significant Tumor Regression."

Cancer Gene Therapy - "In Vivo Targeted Gene Delivery Through FGF Receptors."

Cancer Gene Therapy - "Recombinant Murine IL-2 Expression in H238 Tumor Cells."

Cancer Immunotherapy - "IL-15 and IL-2 May Modify the Sensitivity of Melanoma Cells to Autologous Cytolytic T Cells."

Genetics (Kaposi's Sarcoma) - "Expression of the Proto-Oncogene bcl-2 in Spindle Cells and Occasional Endothelial Cells of Kaposi's Sarcoma in Situ."

Transfusion Medicine - "Survey of Use of Platelet Transfusions in Centres Participating in the MRC Leukaemia Trials."

Melanoma - "Ratio of IgG:IgM Antibodies to Sialyl Lewis(X) and GM(3) Correlates with Tumor Growth after Immunization with Melanoma-Cell Vaccine with Different Adjuvants in Mice."

Cancer Immunotherapy - "In vitro Immunization and Expansion of Antigen-Specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy using Peptide-Pulsed Dendritic Cells."

Cancer Vaccines - "Development and Characterization of a Mouse Prostate Adenocarcinoma Cell Line: Ductal Formation Determined by Extracellular Matrix."

Cancer Vaccines - "HER-2/neu Oncogenic Protein: Issues in Vaccine Development."

Cancer Vaccines - "Immunomodulatory Properties of Antineoplastic Drugs Administered in Conjunction with GM-CSF-Secreting Cancer Cell Vaccines."

Cancer Vaccines - "Induction by DNA Immunization of a Protective Antitumor Cytotoxic T Lymphocyte Response Against a Minimal-Epitope-Expressing Tumor."

Cancer Vaccines - "The Mode of Presentation and Route of Administration Are Critical for the Induction of Immune Responses to p53 and Antitumor Immunity."

Cancer Vaccines - "p53-Based Immunotherapy of Cancer."

Endometrial Cancer - "Menopausal Hormone Use and Endometrial Cancer, by Tumor Grade and Invasion."

Epstein-Barr Virus - "Hepatobiliary Lymphoepithelioma-Like Carcinoma Associated with Epstein-Barr Virus."

Immunology - "Dendritic Cells, Interleukin 12, and CD4⁺ Lymphocytes in the Initiation of Class I-Restricted Reactivity to a Tumor/Self Peptide."

Melanoma - "Co-Expression of Immunogenic Determinants by the Same Cellular Immunogen Is Required for the Optimum Immunotherapeutic Benefit in Mice with Melanoma."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Top Medical Newsletters

Awards

eHealthcare Leadership 2011 Winner

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx on Facebook

Home | About | Medical Topics | Products | Contact | Privacy Policy